Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pagel

Showing results (161-170 of 245) with videos related to

Pageof 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2010
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbiditiesHesham Eissa, Ted A Gooley, Mohamed L Sorror, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic MalignanciesManuela Matesan, Darrell R Fisher, Roger Wong, et al.
British Journal of Haematology|December 16, 2016
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemiaTadeusz Robak, Andrzej Hellmann, Janusz Kloczko, et al.
Blood|February 7, 2012
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsBrian G Till, Michael C Jensen, Jinjuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphomaSteven I Park, Jaideep Shenoi, Shani M Frayo, et al.
Medical Physics|July 3, 2015
Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID cameraBrian W Miller, Sofia H L Frost, Shani L Frayo, et al.
Blood|March 31, 2021
Acalabrutinib in treatment-naive chronic lymphocytic leukemiaJohn C Byrd, Jennifer A Woyach, Richard R Furman, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 15, 2020
Attitudes and Behavior of Health Care Workers Before, During, and After Implementation of Real-Time Location System TechnologyJoan M Griffin, Thomas R Hellmich, Kalyan Sunder Pasupathy, et al.
American Journal of Hematology|December 30, 2014
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasmPamela S Becker, Bruno C Medeiros, Anthony S Stein, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Pageof 25

Showing results (161-170 of 245) with videos related to

Sort By:
Pageof 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2010
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbiditiesHesham Eissa, Ted A Gooley, Mohamed L Sorror, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic MalignanciesManuela Matesan, Darrell R Fisher, Roger Wong, et al.
British Journal of Haematology|December 16, 2016
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemiaTadeusz Robak, Andrzej Hellmann, Janusz Kloczko, et al.
Blood|February 7, 2012
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsBrian G Till, Michael C Jensen, Jinjuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphomaSteven I Park, Jaideep Shenoi, Shani M Frayo, et al.
Medical Physics|July 3, 2015
Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID cameraBrian W Miller, Sofia H L Frost, Shani L Frayo, et al.
Blood|March 31, 2021
Acalabrutinib in treatment-naive chronic lymphocytic leukemiaJohn C Byrd, Jennifer A Woyach, Richard R Furman, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|February 15, 2020
Attitudes and Behavior of Health Care Workers Before, During, and After Implementation of Real-Time Location System TechnologyJoan M Griffin, Thomas R Hellmich, Kalyan Sunder Pasupathy, et al.
American Journal of Hematology|December 30, 2014
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasmPamela S Becker, Bruno C Medeiros, Anthony S Stein, et al.
Blood|July 7, 2012
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSH Joachim Deeg, Bart L Scott, Min Fang, et al.
Pageof 25